- Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator
-
Application No.: US13439379Application Date: 2012-04-04
-
Publication No.: US08598205B2Publication Date: 2013-12-03
- Inventor: Hayley Binch , Lev T. D. Fanning , Dennis Hurley , Urvi Sheth , Alina Silina , Xiaoqing Yang , Martyn Botfield , Peter D. J. Grootenhuis , Fredrick Van Goor , Mehdi Michel Djamel Numa
- Applicant: Hayley Binch , Lev T. D. Fanning , Dennis Hurley , Urvi Sheth , Alina Silina , Xiaoqing Yang , Martyn Botfield , Peter D. J. Grootenhuis , Fredrick Van Goor , Mehdi Michel Djamel Numa
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Christopher C. Forbes; Jonathan P. O'Brien
- Main IPC: C07D215/38
- IPC: C07D215/38 ; A61K31/04
Abstract:
The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.
Public/Granted literature
- US20120208841A1 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator Public/Granted day:2012-08-16
Information query
